The immune landscape of the inflamed joint defined by spectral flow cytometry
Clinical and Experimental Immunology · 2024
DOI: 10.1093/cei/uxae071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, 2024. Verfasst von Meryl H Attrill und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK. Hauptthemen laut MEDLINE: Flow Cytometry, Arthritis, Juvenile, T-Lymphocytes, Regulatory, Synovial Fluid. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research.
Abstract (Originalsprache)
Cellular phenotype and function are altered in different microenvironments. For targeted therapies it is important to understand site-specific cellular adaptations. Juvenile idiopathic arthritis (JIA) is characterized by autoimmune joint inflammation, with frequent inadequate treatment responses. To comprehensively assess the inflammatory immune landscape, we designed a 37-parameter spectral flow cytometry panel delineating mononuclear cells from JIA synovial fluid (SF) of autoimmune inflamed joints, compared to JIA and healthy control blood. Synovial monocytes and NK cells (CD56bright) lack Fc-receptor CD16, suggesting antibody-mediated targeting may be ineffective. B cells and DCs, both in small frequencies in SF, undergo maturation with high 4-1BB, CD71, CD39 expression, supporting T-cell activation. SF effector and regulatory T cells were highly active with newly described co-receptor combinations that may alter function, and suggestion of metabolic reprogramming via CD71, TNFR2, and PD-1. Most SF effector phenotypes, as well as an identified CD4-Foxp3+ T-cell population, were restricted to the inflamed joint, yet specific SF-predominant CD4+ Foxp3+ Treg subpopulations were increased in blood of active but not inactive JIA, suggesting possible recirculation and loss of immunoregulation at distal sites. This first comprehensive dataset of the site-specific inflammatory landscape at protein level will inform functional studies and the development of targeted therapeutics to restore immunoregulatory balance and achieve remission in JIA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK.
- UCL Great Ormond Street Institute of Child Health, Infection, Immunity, and Inflammation Research and Teaching Department, University College London, London, UK.
- Centre for Adolescent Rheumatology Versus Arthritis at UCL UCLH and GOSH, London, UK.
- Centre for Rheumatology, Division of Medicine, University College London, London, UK.
- NIHR Biomedical Research Centre at GOSH, London, UK.
ORCID-Profile: Meryl H Attrill, Diana Shinko, Vicky Alexiou, Melissa Kartawinata, Lucy R Wedderburn, Anne M Pesenacker
Förderung
- National Institute for Health and Care Research
Zitieren
APA
Attrill, M. H., Shinko, D., Alexiou, V., Kartawinata, M., CHARMS study, JIAP study, Wedderburn, L. R., & Pesenacker, A. M. (2024). The immune landscape of the inflamed joint defined by spectral flow cytometry. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxae071
Vancouver
Attrill MH, Shinko D, Alexiou V, Kartawinata M, CHARMS study, JIAP study, et al. The immune landscape of the inflamed joint defined by spectral flow cytometry. Clinical and Experimental Immunology. 2024. doi:10.1093/cei/uxae071
BibTeX
@article{Attrill2024,
author = {Attrill, Meryl H and Shinko, Diana and Alexiou, Vicky and Kartawinata, Melissa and CHARMS study, CHARMS study and JIAP study, JIAP study and Wedderburn, Lucy R and Pesenacker, Anne M},
title = {The immune landscape of the inflamed joint defined by spectral flow cytometry},
journal = {Clinical and Experimental Immunology},
year = {2024},
doi = {10.1093/cei/uxae071}
}
EUVIMED